Demcizumab /dɛmˈsɪzʊmæb/ is a humanized monoclonal antibody which is used to treat patients with pancreatic cancer or non-small cell lung cancer. Demcizumab...
10 KB (1,043 words) - 13:17, 1 September 2023
anti-cancer therapeutic. In the same year, the company sponsored the USAN name demcizumab for a human IgG2 anti-DLL4 antibody, also an anti-cancer therapeutic....
11 KB (822 words) - 18:31, 26 September 2022
Darzalex mab human CD38 Y multiple myeloma Dectrekumab mab human IL-13 Demcizumab mab humanized DLL4 cancer Denintuzumab mafodotin mab humanized CD19 cancer...
135 KB (4,054 words) - 22:35, 2 July 2024
Pharmaceuticals joined a cancer stem cell therapeutic development agreement with demcizumab and five other biologics from OncoMed's pipeline. That same year, Sutro...
32 KB (2,799 words) - 01:10, 23 April 2024
Citatuzumab bogatox§ Clivatuzumab tetraxetan Cofetuzumab pelidotin Dacetuzumab§ Demcizumab§ Dalotuzumab§ Denintuzumab mafodotin§ Elotuzumab Emactuzumab Emibetuzumab§...
5 KB (368 words) - 22:00, 19 October 2020
Citatuzumab bogatox§ Clivatuzumab tetraxetan Cofetuzumab pelidotin Dacetuzumab§ Demcizumab§ Dalotuzumab§ Denintuzumab mafodotin§ Elotuzumab Emactuzumab Emibetuzumab§...
4 KB (241 words) - 11:41, 22 April 2022
Citatuzumab bogatox§ Clivatuzumab tetraxetan Cofetuzumab pelidotin Dacetuzumab§ Demcizumab§ Dalotuzumab§ Denintuzumab mafodotin§ Elotuzumab Emactuzumab Emibetuzumab§...
3 KB (129 words) - 01:04, 19 July 2023